Pale Fire Capital SE’s Neurogene NGNE Stock Holding History

Pale Fire Capital SE’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	+9,460	New	+$260K	0.02%	54

Other funds holding NGNE

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Pale Fire Capital SE's NGNE Position: Q2 2026 in Review

Pale Fire Capital SE opened a new position in Neurogene (NGNE) in Q2 2026: 9,460 shares worth $298K. The stake represents 0.02% of the portfolio and ranks #54 among its holdings.

112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

Pale Fire Capital SE held 9,460 shares of Neurogene worth $298K as of Q2 2026.
Neurogene was a new Pale Fire Capital SE position in Q2 2026.
Neurogene made up 0.02% of Pale Fire Capital SE's portfolio in Q2 2026, its #54 holding.
112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.